Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients

Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer

NCT02245100 ·Status: COMPLETED

Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors

NCT03596593 ·Status: UNKNOWN ·Phase: NA

Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia

NCT02330718 ·Status: UNKNOWN

Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients

NCT05254821 ·Status: RECRUITING

DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402

NCT01406782 ·Status: COMPLETED

Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma

NCT00981097 ·Status: COMPLETED

Association Between Mitochondrial DNA Content and Risk of Acute Leukemia

NCT03595969 ·Status: COMPLETED

Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms

NCT01390597 ·Status: COMPLETED

Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis

NCT03868215 ·Status: UNKNOWN

Circulating DNA in Surgically Treated NSCLC

NCT04037150 ·Status: UNKNOWN

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

NCT02269592 ·Status: RECRUITING

Biology Studies of Hematologic Cancers

NCT00923442 ·Status: ENROLLING_BY_INVITATION

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00003863 ·Status: COMPLETED

A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer

NCT03749083 ·Status: WITHDRAWN

Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas

NCT05676450 ·Status: RECRUITING ·Phase: NA

Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.

NCT05083494 ·Status: UNKNOWN

DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma

NCT01419509 ·Status: COMPLETED

Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA

NCT04104633 ·Status: COMPLETED ·Phase: NA

Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia

NCT01016379 ·Status: COMPLETED

ctDNA-MRD Monitoring After Resection in Gastric Cancer

NCT06893133 ·Status: RECRUITING

Circulating Tumor DNA Exposure in Peripheral Blood

NCT03517332 ·Status: UNKNOWN

A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration

NCT06564428 ·Status: RECRUITING

Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients

NCT00213798 ·Status: COMPLETED ·Phase: NA

Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire

NCT03614689 ·Status: ACTIVE_NOT_RECRUITING

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma

NCT00004153 ·Status: COMPLETED ·Phase: NA